Home › Glioblastoma › Minnesota › Rochester
Pag-aaral pangklinika para sa Glioblastoma sa Rochester, MN
Isang pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Nagre-recruitPhase 2
- Mayo Clinic in Rochester, Rochester
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Nagre-recruitPhase 1/2
- Mayo Clinic in Rochester, Rochester
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
- Mayo Clinic - Rochester, Rochester
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
Nagre-recruitMaagang Phase 1
- Mayo Clinic in Rochester, Rochester
Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
Nagre-recruit
- Mayo Clinic in Rochester, Rochester
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Nagre-recruit
- Mayo Clinic in Rochester, Rochester
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
Nagre-recruit
- Mayo Clinic in Rochester, Rochester
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Nagre-recruitPhase 2
- Mayo Clinic, Rochester
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Nagre-recruitPhase 1/2
- Mayo Clinic in Rochester, Rochester
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Nagre-recruitPhase 1
- Mayo Clinic in Rochester, Rochester
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Nagre-recruitPhase 1/2
- Mayo Clinic Hospital, Rochester
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Nagre-recruitPhase 1/2
- Mayo Clinic Cancer Center, Rochester
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Nagre-recruitPhase 2
- Mayo Clinic, Rochester
Pag-aaral para sa Glioblastoma sa ibang lungsod
- New York City, NY30 pag-aaral
- Boston, MA28 pag-aaral
- Houston, TX26 pag-aaral
- Los Angeles, CA24 pag-aaral
- Durham, NC20 pag-aaral
- San Francisco, CA17 pag-aaral
- Chicago, IL15 pag-aaral
- Washington, DC15 pag-aaral
- Miami, FL14 pag-aaral
- Columbus, OH14 pag-aaral
- Jacksonville, FL13 pag-aaral
- Aurora, CO12 pag-aaral
Iba pang pag-aaral sa Rochester
- Kanser sa Suso42 pag-aaral
- Non-Small Cell Lung Cancer37 pag-aaral
- Metastatic Cancer31 pag-aaral
- Kanser (lahat ng uri)30 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Colorectal Cancer29 pag-aaral
- Multiple Myeloma24 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Kanser sa Pancreas22 pag-aaral
- Kanser ng Endometrium20 pag-aaral
- Kanser sa Baga20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.